Gamification to Improve Medication Adherence: A Mixed-method Usability Study for MedScrab.
Yan LiHuong PhanAnandi V LawAndrius BaskysDon RoosanPublished in: Journal of medical systems (2023)
Medication non-adherence is a prevalent healthcare problem with poor health outcomes and added healthcare costs. MedScrab, a gamification-based mHealth app, is the first attempt to deliver crucial life-saving medication information to patients and increase their medication adherence. The paper presents the development of MedScrab and a two-phase mixed-method usability evaluation of MedScrab. Phase I qualitatively evaluated MedScrab using a think-aloud protocol for its usability. With 51 participants, qualitative data analysis of Phase I revealed two themes: positive functionality of the app and four areas of improvement. The improvement recommendations were incorporated into MedScrab's design. Phase I also validated a widely used mHealth App Usability Questionnaire (MAUQ). Quantitative data analysis of Phase I reduced the original 18-item MAUQ scale to a 15-item scale with two factors: ease of use (4 items) and usefulness and satisfaction (11 items). Phase II surveyed 83 participants from Amazon's Mechanical Turk using a modified MAUQ. The modified MAUQ scale showed strong internal consistency (Cronbach alpha = 0.959) and high factor loadings (between 0.623 and 0.987). The study design of the usability evaluation can serve as a methodological guide for designing, evaluating, and improving mHealth apps.The usability study showed that MedScrab was perceived as ease of use (6.24 out of 7) with high usefulness and satisfaction (5.72 out of 7). The quantitative data analysis results support the use of the modified MAUQ as a valid instrument to measure the usability of the MedScrab. However, the instrument should be used with adaptation based on the app's characteristics.
Keyphrases
- electronic health record
- health information
- healthcare
- data analysis
- adverse drug
- phase ii
- social media
- clinical trial
- end stage renal disease
- randomized controlled trial
- open label
- chronic kidney disease
- high resolution
- physical activity
- newly diagnosed
- mass spectrometry
- patient reported outcomes
- psychometric properties
- type diabetes
- emergency department
- metabolic syndrome
- social support
- single cell
- clinical practice
- patient reported
- health insurance
- phase iii
- glycemic control